European Archives - Page 1009 of 1113 - European Medical Journal

EMJ

Evaluating genomic tests for breast cancer management

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute, Milan, Italy…

Safety and Clinical Benefit of HSC Gene Therapy for Wiskott-Aldrich Syndrome

Press brief by Francesca Ferrua, MD, at the American Society of Hematology (ASH) 2015 annual meeting. Dr Ferrua provides an update on the safety and…

Lentiviral HSC Gene Therapy for Older Patients with X-Linked Severe Combined Immunodeficiency

Press brief by Suk See De Ravin, MD, PhD, at the American Society of Hematology (ASH) 2015 annual meeting. Dr De Ravin gives an overview of how…

EMJ

Helsinn Celebrates its 40th Anniversary

Lugano, Switzerland, January 11, 2016: Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, is delighted to launch its 40th…

EMJ

European Pain Federation EFIC® Launches New Information Campaign

In calling for the “European Year Against Joint Pain”, the European Pain Federation EFIC® is devoting itself this year to an especially widespread…

EMJ

Organoids: Mini-Organs for Gastrointestinal Research

RESEARCH on the intestine is a rapidly evolving field for a multitude of reasons, not least due to the incredible progress made in the development of…

EMJ

Signature 3: A New Hope for Gastric Cancer Patients

SIGNATURE 3, a specific genomic molecular fingerprint, represents a fresh avenue of investigation for physicians and researchers aiming to…

EMJ

How Giant Cells Dispose of Giant Waste

PHAGOCYTIC multinucleated giant cells (MGCs) act as the waste disposal men of the body by clearing away bulky waste materials that carry the potential…

EMJ

How the Body Stops the Type 2 Immune Response and Onset of Allergic Disease

SUPPRESSION of group 2 innate lymphoid (IL2) cells following infection has been shown to prevent the innate immune response from continuing when…

EMJ

Genome-Wide Meta-Analysis Provides Insight into the ‘Atopic March’

SEVEN genetic risk loci have been identified for the ‘atopic march’, the sequential progression of different allergic conditions frequently seen in…